0000897423-18-000055.txt : 20180726
0000897423-18-000055.hdr.sgml : 20180726
20180726145947
ACCESSION NUMBER: 0000897423-18-000055
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180724
FILED AS OF DATE: 20180726
DATE AS OF CHANGE: 20180726
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bratton Capital Inc.
CENTRAL INDEX KEY: 0001723783
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38599
FILM NUMBER: 18971433
BUSINESS ADDRESS:
STREET 1: 201 MAIN STREET
STREET 2: SUITE 1900
CITY: FORT WORTH
STATE: TX
ZIP: 76102
BUSINESS PHONE: 817.339.7600
MAIL ADDRESS:
STREET 1: 201 MAIN STREET
STREET 2: SUITE 1900
CITY: FORT WORTH
STATE: TX
ZIP: 76102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bratton Capital Management, L.P.
CENTRAL INDEX KEY: 0001723787
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38599
FILM NUMBER: 18971434
BUSINESS ADDRESS:
STREET 1: 201 MAIN STREET
STREET 2: SUITE 1900
CITY: FORT WORTH
STATE: TX
ZIP: 76102
BUSINESS PHONE: 817.339.7600
MAIL ADDRESS:
STREET 1: 201 MAIN STREET
STREET 2: SUITE 1900
CITY: FORT WORTH
STATE: TX
ZIP: 76102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Monoline Partners, L.P.
CENTRAL INDEX KEY: 0001747211
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38599
FILM NUMBER: 18971435
BUSINESS ADDRESS:
STREET 1: C/O BRATTON CAPITAL MANAGEMENT
STREET 2: 201 MAIN STREET, SUITE 1900
CITY: FORT WORTH
STATE: TX
ZIP: 76102
BUSINESS PHONE: 817-339-7600
MAIL ADDRESS:
STREET 1: C/O BRATTON CAPITAL MANAGEMENT
STREET 2: 201 MAIN STREET, SUITE 1900
CITY: FORT WORTH
STATE: TX
ZIP: 76102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BRATTON DOUGLAS K
CENTRAL INDEX KEY: 0001281933
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38599
FILM NUMBER: 18971436
MAIL ADDRESS:
STREET 1: 201 MAIN STREET
STREET 2: SUITE 1900
CITY: FORT WORTH
STATE: TX
ZIP: 76102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aquestive Therapeutics, Inc.
CENTRAL INDEX KEY: 0001398733
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208623253
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 30 TECHNOLOGY DRIVE
CITY: WARREN
STATE: NJ
ZIP: 07059
BUSINESS PHONE: 908-941-1900
MAIL ADDRESS:
STREET 1: 30 TECHNOLOGY DRIVE
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER COMPANY:
FORMER CONFORMED NAME: MonoSol Rx, Inc.
DATE OF NAME CHANGE: 20070507
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-07-24
0001398733
Aquestive Therapeutics, Inc.
AQST
0001281933
BRATTON DOUGLAS K
201 MAIN STREET
SUITE 1900
FORT WORTH
TX
76102
1
0
1
0
0001747211
Monoline Partners, L.P.
C/O BRATTON CAPITAL MANAGEMENT
201 MAIN STREET, SUITE 1900
FORT WORTH
TX
76102
0
0
1
0
0001723787
Bratton Capital Management, L.P.
201 MAIN STREET
SUITE 1900
FORT WORTH
TX
76102
0
0
1
0
0001723783
Bratton Capital Inc.
201 MAIN STREET
SUITE 1900
FORT WORTH
TX
76102
0
0
1
0
Common Stock
2018-07-24
4
P
0
165000
15.00
A
165000
I
See Footnotes
Common Stock
75085
D
Common Stock
2249077
I
See Footnotes
Common Stock
2213314
I
See Footnotes
Common Stock
4032907
I
See Footnotes
Common Stock
2755541
I
See Footnotes
Common Stock
87455
I
See Footnotes
These securities are beneficially owned by MonoLine Partners, L.P. ("MonoLine").
These securities are owned, as indicated, by MonoLine, MRX Partners, LLC ("MRX Partners"), MonoLine Rx, L.P. ("Monoline Rx"), MonoLine Rx II, L.P. ("Monoline II"), and MonoLine Rx III, L.P. ("Monoline III"), respectively. Monoline, MRX Partners, Monoline Rx, Monoline II, and Monoline III are referred to herein collectively as the "Monoline Entities". Bratton Capital Management, L.P. ("Bratton Capital Management") is the general partner of each of the Monoline Entities. Bratton Capital, Inc. ("Bratton") is the general partner of Bratton Capital Management. The Reporting Person, Douglas K. Bratton, is the sole director of Bratton and has voting and investment power over all shares held by the Monoline Entities.
These securities are beneficially owned by MRX Partners.
These securities are beneficially owned by Monoline Rx.
These securities are beneficially owned by Monoline II.
These securities are beneficially owned by Monoline III.
These securities are beneficially owned by MonoSol Rx Genpar, L.P. ("Monosol"). Bratton is the general partner of Monosol. The Reporting Person, Douglas K. Bratton, is the sole director of Bratton and has voting and investment power over all shares held by Monosol.
Bratton Capital Management, Bratton, and Mr. Bratton may each be deemed to own beneficially all shares owned by the Monoline Entities, and Bratton and Mr. Bratton may be deemed to beneficially own all shares held by Monosol. Each such entity and Mr. Bratton disclaims beneficial ownership of the reported securities except to the extent of its or his respective pecuniary interest therein.
/s/ Douglas K. Bratton
2018-07-26
/s/ John Cochran, Vice President of Bratton Capital, Inc., general partner of Bratton Capital Management, L.P., general partner of MonoLine Partners, L.P.
2018-07-26
/s/ John Cochran, Vice President of Bratton Capital, Inc., general partner of Bratton Capital Management, L.P.
2018-07-26
/s/ John Cochran, Vice President of Bratton Capital, Inc.
2018-07-26